Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever

Eur J Pharmacol. 1988 Sep 13;154(2):145-52. doi: 10.1016/0014-2999(88)90091-x.


Blood prostaglandin E2 (PGE2) levels, estimated by radioimmunoassay, and body temperatures of conscious rabbits were measured simultaneously during fever in response to polyinosinic: polycytidylic acid, lipopolysaccharide and interleukin 1/endogenous pyrogen. The effects of the antipyretic agent ketoprofen on both parameters was also studied. Significant rises (in the order of 6- to 8-fold) in the PGE2 level were observed after injection of either of the three pyrogens and occurred simultaneously with the rise in temperature. Ketoprofen given after the onset of fever in response to the pyrogens produced an immediate defervescence and a simultaneous decrease in plasma PGE2. Ketoprofen given before the pyrogens prevented any rise in either body temperature or plasma PGE2 level. When animals were subjected to an environmental temperature of 34 degrees C a hyperthermia was observed without any change in the blood PGE2 level. These results suggest that an increase in the blood PGE2 level may contribute to the pathogenesis of fever.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Temperature / drug effects
  • Dinoprostone / blood*
  • Fever / blood*
  • Interleukin-1 / pharmacology
  • Ketoprofen / pharmacology
  • Lipopolysaccharides / pharmacology*
  • Male
  • Poly I-C / pharmacology
  • Pyrogens / pharmacology*
  • Rabbits
  • Radioimmunoassay
  • Time Factors


  • Interleukin-1
  • Lipopolysaccharides
  • Pyrogens
  • Ketoprofen
  • Dinoprostone
  • Poly I-C